Deven Choksey of DRChoksey Finserv expects Tata Sons to list eventually, naming Tata Chemicals as the top beneficiary. He also backs the NSE IPO for its profit distribution and calls large-cap valuations compelling right now.
Deven Choksey of DRChoksey Finserv expects Tata Sons to list eventually, naming Tata Chemicals as the top beneficiary. He also backs the NSE IPO for its profit distribution and calls large-cap valuations compelling right now.